2025-2026 Trivalent Influenza Virus Vaccine in Pre-filled Syringes

The Department of Health and Human Services Office of the Assistant Secretary for Administration is seeking to procure 2025-2026 Trivalent Influenza virus vaccine in pre-filled syringes for the upcoming flu season. The procurement requires vaccines packaged in units of 10 syringes per package, falling under the Biological Product Manufacturing NAICS category 325414 and PSC category 6505 for Drugs and Biologicals. This pre-solicitation notice was posted on August 6, 2025, with responses due by August 15, 2025, providing potential contractors with a nine-day window to prepare their submissions. The opportunity represents a standard federal procurement without any small business set-aside designations. The notice does not specify evaluation criteria or contractor qualifications at this pre-solicitation stage, though these details will likely be provided in the formal solicitation document.

The contract opportunity does not utilize any set-aside programs, making it open to all qualified contractors regardless of business size or socioeconomic status. The total quantity required is 563 packages, which translates to 5,630 individual pre-filled vaccine syringes for the 2025-2026 influenza season. No incumbent contractors or potential award values are mentioned in this pre-solicitation notice, as is typical for early-stage procurement announcements. The relatively small quantity suggests this procurement may be for a specific federal facility or program rather than a large-scale government-wide vaccine acquisition. The tight timeline between posting and response deadline indicates the agency's urgency in securing vaccine supplies for the upcoming influenza season. No information about contract duration or delivery timeline is provided in this initial notice.